International Clinical Trial: Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532148) titled 'Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer' on April 9.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Chong Kun Dang Pharmaceutical

Condition: Ovarian Cancer

Intervention: Drug: CKD-215

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: June 2026

Target Sample Size: 24

To know more, visit https://clinicaltrials.gov/study/NCT07532148

Published by HT Digital Content Service...